<div id="readability-page-1"><p>In a report released yesterday,  from GF Securities maintained a Buy rating on Alibaba Health Information Technology, with a price target of <span id="expert-recommendation-target">HK$7.39</span>.</p><h3>Valentine's Day Sale - 70% Off</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  and maximize your portfolio's potential</li></ul>  <p>In addition to GF Securities, Alibaba Health Information Technology also received a Buy from TipRanks – xAI’s xAi Medical – Pharmaceuticals in a report issued on February 8. However, on the same day, TipRanks – OpenAI reiterated a Hold rating on Alibaba Health Information Technology (Other OTC: ALBHF).</p></div>

159849

159898

589720

00241

513120

516610

516930

159883

159837

<p>GF Securities has maintained a Buy rating on Alibaba Health Information Technology (ALBHF) with a price target of HK$7.39. Additionally, TipRanks also issued a Buy rating for the company, while another report reiterated a Hold rating on the same day.</p>

Tip Ranks

China Merchants CSI Biotechnology Theme ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

Guotai SSE STAR Brand Name Drug ETF

ALI HEALTH

GF CSI HK Innovative Drugs Industry ETF(QDII)

Dacheng CSI All Share Health Care Equipment and Services ETF

Minsheng Royal CSI Biotechnology Theme ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

E Fund CSI Biotechnology Theme ETF

GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)